Paul Tudor Jones Moderna, Inc. Transaction History
Tudor Investment Corp Et Al
- $25.1 Billion
- Q4 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Moderna, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 353,865 shares of MRNA stock, worth $12.5 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
353,865
Previous 153,098
131.14%
Holding current value
$12.5 Million
Previous $10.2 Million
43.81%
% of portfolio
0.06%
Previous 0.04%
Shares
13 transactions
Others Institutions Holding MRNA
# of Institutions
924Shares Held
256MCall Options Held
19MPut Options Held
24.3M-
Vanguard Group Inc Valley Forge, PA40.3MShares$1.42 Billion0.03% of portfolio
-
Baillie Gifford & CO38.9MShares$1.37 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$900 Million0.07% of portfolio
-
State Street Corp Boston, MA17.6MShares$619 Million0.03% of portfolio
-
Theleme Partners LLP London, X07.31MShares$257 Million20.37% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $13.8B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...